About
Technology
Issues
FAQ
Links
Official Page
A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: A Gynecologic Oncology Group study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.